
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$261.1m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.62
7D
0%
1Y
596.6%
Clinuvel Pharmaceuticals
Market Cap: AU$458.9m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.10
7D
-3.9%
1Y
-14.6%